Like fingerprints, no two cancers are exactly the same. And yet cancer care – especially for those in the most advanced stages, and with the most complex cases – is administered according to standard, linear protocols. Clinical trials, too, rely on examining one course of treatment against another without modifying the trial based on actual patient outcomes. Cancers are dynamic. They build resistance. They adapt. So why don’t we adapt cancer treatment for each individual, each tumour?

In this episode, Juliet sits down with Dr. Jack Kreindler to talk about adaptive oncology, the challenges of putting it into practice, and the opportunities for startups to address the massive unmet need in cancer treatment. Dr. Jack is a leading expert in health optimisation, co-founder of the Centre for Health and Human Performance, a serial- entrepreneur, and our very own Venture Partner here at Mosaic.